Synopsis:
Clean Science and Technology Ltd slumped upto 9% as 24% equity stake exchanged hands, and promoters are likely the sellers.
The global chemical manufacturing company is in the news today as its shares slumped by upto 7 percent because its promoters intend to sell a large portion of their stake in block deals, which could result in a significant change in ownership and attract strong investor interest.
With a market capitalization of Rs. 12,065 crore, Clean Science and Technology Limited is trading at Rs. 1,130.20, down by 4.29 percent from its previous close of Rs. 1,180.80 per equity share. The stock has reached a low of Rs. 1,070.50 in today’s trading session.
What’s the News?
According to sources, around 24 percent equity stake of Clean Science and Technology Limited exchanged hands, and promoters Ashok Boob and Krishna Boob were likely the sellers as they were expected to sell their stake in the company through block deals. The total offer size is estimated at Rs. 2,626 crore, with a floor price of Rs. 1,030 per share.
As of June 2025, Ashok Ramnarayan Boob holds a 12.8 percent stake, while Ashok Ramnarayan Boob HUF owns 5.51 percent in the company. Similarly, Prasad Krishnakumar Boob and Prasad Krishnakumar Boob HUF hold 3.22 percent and 3.04 percent stakes, respectively.
According to Moneycontrol, shares of Clean Science and Technology recovered after falling 7 percent on August 21, as the firm clarified that the decline was caused by a punching error by broker Spark Avendus, which resulted in over six crore shares changing hands in a block deal instead of the expected 2.5 crore shares. It added that only 2.5 crore shares, or 24 percent of its equity, were intended to be exchanged.
Also Read: Stock to buy now for an upside of 28%; Recommended by Motilal Oswal
About the company
Clean Science and Technology Ltd, founded in 2003, is one of the world’s fastest-growing and most profitable fine and specialty chemical manufacturers. It is one of the largest producers of several in-house developed specialty chemicals, with a strong emphasis on innovative, sustainable, and cost-effective catalytic processing.
The company serves 500+ customers in 35+ countries, generates 63 percent of its revenue from exports, and has zero debt. Its operations include four manufacturing units, a pilot facility, an application lab, and four R&D centers with over 90 scientists.
With 16+ accreditations, a workforce of 1,500 people (10 percent women), and strong ESG practices, the company manufactures critical specialty chemicals spanning performance chemicals, pharmaceutical intermediates, and FMCG chemicals.
The company’s revenue from operations increased by 8.48 percent from Rs. 224 crore in Q1 FY25 to Rs. 243 crore in Q1 FY26. However, it decreased by 7.95 percent from Rs. 264 crore in Q4 FY25. Similarly Net profit of the company increased by 6.06 percent from Rs. 66 crore to Rs. 70 crore yearly but decreased by 5.41 percent from Rs. 74 crore in Q4 FY25.
It is trading at a price-to-earnings (P/E) ratio of 46x, which is higher than the industry average of 33.1x. A return on equity (ROE) of about 21.9 percent and a return on capital employed (ROCE) of about 29.3 percent demonstrate the company’s financial position.
Written by Akshay Sanghavi
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
